Caixin
BUSINESS & TECH

Big Pharmaceuticals Seek New Prescription for China Sales

By Li Yan and Han Wei
An employee of German pharmaceutical company Bayer AG inspects containers of acetylsalicylic acid in October 2012 before shipping them to a plant in Asturias, Spain.  Photo:IC
An employee of German pharmaceutical company Bayer AG inspects containers of acetylsalicylic acid in October 2012 before shipping them to a plant in Asturias, Spain. Photo:IC

(Beijing) — Multinational drugmakers are pouring hundreds of millions of dollars into new production and research operations in China to expand their foothold in the world’s fastest-growing health care market, even as the government demands sharply lower prices.

In mid-November, German drug giant Bayer AG said it would invest 100 million euros ($104 million) to double its drug packaging capacity in Beijing, creating the largest such Bayer plant in the world. Two weeks earlier, Germany’s Merck Group agreed to invest 170 million euros in a drug factory in Nantong, Jiangsu province. By 2021, it will be Merck’s largest facility outside Europe, producing 10 billion pills a year.

You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
Copyright ©2017 Caixin Global Limited. All Rights Reserved.